Active, not recruiting |
: Special Investigation (All Case Survey) in Patients With Juvenile Idiopathic Arthritis
: Arthritis, Juvenile Rheumatoid
: 2011-08-05
|
Completed |
: Study of Human Anti-TNF Monoclonal Antibody Adalimumab in Children With Polyarticular Juvenile Idiopathic Arthritis (JIA)
: Arthritis, Juvenile Idiopathic
: 2002-11-01
: - Biological: Double-Blind Adalimumab/Placebo + MTX
|
Terminated |
: Study To Determine The Pharmacokinetics Of Sulfasalazine In Children With Juvenile Idiopathic Arthritis
: Arthritis, Juvenile Rheumatoid
: 2008-03-11
: Drug: Sulfasalazine Sulfasalazine delayed release tablets 30-60 mg/kg/day (divided into BID doses) for 7
|
Recruiting |
: A Study to Evaluate the Pharmacokinetics, Efficacy and Safety of Intravenous Golimumab in Pediatric Participants With Active Polyarticular Course Juvenile Idiopathic Arthritis Despite Methotrexate Therapy
: Arthritis, Juvenile
: 2014-10-27
: - Drug: Golimumab Golimumab 80 m
|
Completed |
: Safety, Efficacy and Pharmacokinetics of Subcutaneous ACZ885 in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA)
: Arthritis, Juvenile Rheumatoid
: 2007-01-23
: Drug: ACZ885
|
Not yet recruiting |
: Identification of Genes Involved in Juvenile Idiopathic Arthritis by Wholel Exome Sequencing
: Arthritis, Juvenile Rheumatoid
: 2014-02-13
: Biological: Blood sample Blood sample
|
Recruiting |
: Juvenile Arthritis Quantitative Imaging
: - Arthritis, Juvenile Idiopathic
- Enthesitis-Related
- Other: MRI scan (adolescent spine protocol)
|
Terminated |
: Naturalistic Safety Registry Of Celecoxib (CELEBREX(R)) And NSAIDs In Juvenile Idiopathic Arthritis
: Arthritis, Juvenile Rheumatoid
: 2008-05-29
: - Drug: Celecoxib Non-interventi
|
Completed |
: A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Juvenile Rheumatoid Arthritis
: Rheumatoid Arthritis, Juvenile
: 2002-05-09
: Drug: Infliximab
|
Completed |
: Safety and Efficacy of Measles, Mumps, Rubella Vaccination in Juvenile Idiopathic Arthritis
: Arthritis, Juvenile Rheumatoid
: 2008-08-06
: Biological: Measles, Mumps, Rubella vaccination Dosage: 1 dose MMR vaccine, containing 5000 p.f.u. (plaq
|